Metascan

N/A

Report date: 2023/06/26 09:15:38

NME

Base Information

Drug NameMetascan

Drug Alias NameAS-101-Antisoma

ClassificationDiagnostic agent (In vivo)Small molecules

Mechanisms of ActionRadionuclide imaging enhancers

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAntisoma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAntisoma

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A